Intraperitoneal Administration of Low Dose Aluminium in The Rat How Good is It to Produce a Model for Alzheimer Disease
Yazarlar (14)
Hasan Basri Ulusoy Erciyes University, Faculty of Medicine, Türkiye
M. F. Sonmez Erciyes University, Faculty of Medicine, Türkiye
E. Kilic Erciyes University, Faculty of Medicine, Türkiye
K. Caliskan Erciyes University, Faculty of Medicine, Türkiye
B. Karaca Erciyes University, Faculty of Medicine, Türkiye
M. Kara Erciyes University, Faculty of Medicine, Türkiye
O. Ercal Erciyes University, Faculty of Medicine, Türkiye
Y. Gunduz Erciyes University, Faculty of Medicine, Türkiye
D. Karabulut Erciyes University, Faculty of Medicine, Türkiye
Dr. Öğr. Üyesi Soner BİTİKTAŞ Kafkas Üniversitesi, Türkiye
B. Tan Erciyes University, Faculty of Medicine, Türkiye
S. Kavraal Erciyes University, Faculty of Medicine, Türkiye
A. Inal Erciyes University, Faculty of Medicine, Türkiye
C. Suer Erciyes University, Faculty of Medicine, Türkiye
Devamını Göster...
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Archives Italiennes De Biologie (Q4)
Dergi ISSN 0003-9829 Dergi Bilgileri (2015)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 12-2015
Kabul Tarihi – Yayınlanma Tarihi 01-01-2016
Cilt / Sayı / Sayfa 153 / 4 / 266–278 DOI 10.12871/00039829201543
Makale Linki http://www.architalbiol.org/index.php/aib/article/view/153266
UAK Araştırma Alanları
Fizyoloji
Özet
Since neurotoxicity of aluminium (Al) resembles the progressive neurodegeneration observed in Alzheimer Disease (AD), Al administration in several ways has been used to produce AD model. Intraperitoneal (ip) low dose (4.2 mg/ kg) Al injection in rats for long periods is the preferred method by some researchers. In this paper, the efficiency of this method for producing an AD model was evaluated. In this study, we looked at the neuropathology of Al and the characteristic lesions of AD by histological and immunohistochemical techniques and determined oxidative stress markers in the brains of Al-treated and control rats. We also made electrophysiological recordings at the hippocampus and evaluated possible behavioural changes by Morris water maze test. However, no pathologic changes occurred in the animals except for an impairment in long-term potentiation (LTP) in the hippocampus (e.g. the LTPs of population spike (PS) amplitude at 15 min post-tetanus were measured as 217±27% in Al-treated rats and as 240±42% in sham-treated rats, of baseline PS amplitude). According to the findings of the present study, low dose of ip Al in rats is not sufficient to produce a good AD model. Higher doses (≥ 10 mg/kg) should be used.
Anahtar Kelimeler
Aluminium | Alzheimer disease | Immunohistochemistry | Long-term potentiation | Oxidative stress
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Yöksis 17
Scopus 11
Google Scholar 18
Intraperitoneal Administration of Low Dose Aluminium in The Rat How Good is It to Produce a Model for Alzheimer Disease